{"id":"https://openalex.org/W7204605157","doi":"https://doi.org/10.6084/m9.figshare.33372258","title":"Repositioning omalizumab in Dermatology: emerging indications and mechanism-based Therapeutic Insights","display_name":"Repositioning omalizumab in Dermatology: emerging indications and mechanism-based Therapeutic Insights","alternate_titles":[],"publication_year":2026,"publication_date":"2026-08-28","ids":{"openalex":"https://openalex.org/W7204605157","doi":"https://doi.org/10.6084/m9.figshare.33372258"},"language":"en","primary_location":{"id":"doi:10.6084/m9.figshare.33372258","doi":"https://doi.org/10.6084/m9.figshare.33372258","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33372258","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"parent_works":[],"lineage":["https://openalex.org/W7204605157"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["datacite"],"open_access":{"is_oa":true,"oa_status":"green","oa_url":"https://doi.org/10.6084/m9.figshare.33372258","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5052043896","display_name":"Sunil Dogra","orcid":"https://orcid.org/0000-0001-9912-0085","observed_orcids":["https://orcid.org/0000-0001-9912-0085"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sunil Dogra","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109795946","display_name":"Sahibpreet Kaur","orcid":"https://orcid.org/0009-0009-9028-0635","observed_orcids":["https://orcid.org/0009-0009-9028-0635"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sahibpreet Kaur","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5061087597","display_name":"Muthu Sendhil Kumaran","orcid":"https://orcid.org/0000-0002-8091-101X","observed_orcids":["https://orcid.org/0000-0002-8091-101X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Muthu Sendhil Kumaran","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":0.5067999958992004,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11730","display_name":"Autoimmune Bullous Skin Diseases","score":0.5067999958992004,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12438","display_name":"Urticaria and Related Conditions","score":0.27950000762939453,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10837","display_name":"Dermatology and Skin Diseases","score":0.1298999935388565,"subfield":{"id":"https://openalex.org/subfields/2708","display_name":"Dermatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/omalizumab","display_name":"omalizumab","score":1.0},{"id":"https://openalex.org/keywords/drug-repurposing","display_name":"drug repurposing","score":0.890999972820282},{"id":"https://openalex.org/keywords/anti-ige-monoclonal-antibody","display_name":"anti-IgE monoclonal antibody","score":0.8939999938011169},{"id":"https://openalex.org/keywords/chronic-spontaneous-urticaria","display_name":"chronic spontaneous urticaria","score":0.9750000238418579},{"id":"https://openalex.org/keywords/bullous-pemphigoid","display_name":"bullous pemphigoid","score":0.8949999809265137},{"id":"https://openalex.org/keywords/mastocytosis","display_name":"mastocytosis","score":0.8429999947547913},{"id":"https://openalex.org/keywords/prurigo-nodularis","display_name":"prurigo nodularis","score":0.9980000257492065},{"id":"https://openalex.org/keywords/hyper-ige-syndrome","display_name":"hyper-IgE syndrome","score":0.9980000257492065},{"id":"https://openalex.org/keywords/eosinophilic-dermatoses","display_name":"eosinophilic dermatosis","score":0.9959999918937683},{"id":"https://openalex.org/keywords/chronic-inducible-urticaria","display_name":"chronic inducible urticaria","score":0.8740000128746033},{"id":"https://openalex.org/keywords/biomarker-stratified-trial","display_name":"biomarker-stratified trial","score":0.824999988079071},{"id":"https://openalex.org/keywords/mast-cell-activation","display_name":"mast cell activation","score":0.6169999837875366},{"id":"https://openalex.org/keywords/serum-ige","display_name":"serum IgE","score":0.4959999918937683},{"id":"https://openalex.org/keywords/dupilumab","display_name":"dupilumab","score":0.9139999747276306},{"id":"https://openalex.org/keywords/biosimilars","display_name":"biosimilars","score":0.7289999723434448},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8080000281333923}],"concepts":[{"id":"https://openalex.org/C2778564945","wikidata":"https://www.wikidata.org/wiki/Q415392","display_name":"Omalizumab","level":4,"score":0.9697999954223633},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9067000150680542},{"id":"https://openalex.org/C59491497","wikidata":"https://www.wikidata.org/wiki/Q864715","display_name":"Biosimilar","level":2,"score":0.6808000206947327},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.5777000188827515},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.5616999864578247},{"id":"https://openalex.org/C2779824493","wikidata":"https://www.wikidata.org/wiki/Q5315925","display_name":"Dupilumab","level":3,"score":0.5468999743461609},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.4875999987125397},{"id":"https://openalex.org/C2779786854","wikidata":"https://www.wikidata.org/wiki/Q7444755","display_name":"Secukinumab","level":4,"score":0.4675999879837036},{"id":"https://openalex.org/C2777832160","wikidata":"https://www.wikidata.org/wiki/Q3306175","display_name":"Mepolizumab","level":4,"score":0.3921999931335449},{"id":"https://openalex.org/C2778329239","wikidata":"https://www.wikidata.org/wiki/Q268667","display_name":"Atopic dermatitis","level":2,"score":0.37549999356269836},{"id":"https://openalex.org/C2779252107","wikidata":"https://www.wikidata.org/wiki/Q1004647","display_name":"Bullous pemphigoid","level":3,"score":0.37529999017715454},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3598000109195709},{"id":"https://openalex.org/C2781406822","wikidata":"https://www.wikidata.org/wiki/Q904140","display_name":"Tryptase","level":3,"score":0.3384000062942505},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.33799999952316284},{"id":"https://openalex.org/C2779473830","wikidata":"https://www.wikidata.org/wiki/Q1540899","display_name":"MEDLINE","level":2,"score":0.31369999051094055},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.31220000982284546},{"id":"https://openalex.org/C163864487","wikidata":"https://www.wikidata.org/wiki/Q6901461","display_name":"Monoclonal","level":4,"score":0.3041999936103821},{"id":"https://openalex.org/C141105273","wikidata":"https://www.wikidata.org/wiki/Q79455","display_name":"Immunoglobulin E","level":3,"score":0.2939000129699707},{"id":"https://openalex.org/C141330323","wikidata":"https://www.wikidata.org/wiki/Q2354820","display_name":"Evidence-based practice","level":3,"score":0.2831999957561493},{"id":"https://openalex.org/C2779745271","wikidata":"https://www.wikidata.org/wiki/Q13574436","display_name":"Ixekizumab","level":5,"score":0.27810001373291016},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.27619999647140503},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.266400009393692},{"id":"https://openalex.org/C2779974597","wikidata":"https://www.wikidata.org/wiki/Q28448986","display_name":"Clinical Practice","level":2,"score":0.26589998602867126},{"id":"https://openalex.org/C207480886","wikidata":"https://www.wikidata.org/wiki/Q42982","display_name":"Allergy","level":2,"score":0.25920000672340393}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.6084/m9.figshare.33372258","doi":"https://doi.org/10.6084/m9.figshare.33372258","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33372258","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},{"id":"doi:10.6084/m9.figshare.33372258.v1","doi":"https://doi.org/10.6084/m9.figshare.33372258.v1","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33372258.v1","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"}],"best_oa_location":{"id":"doi:10.6084/m9.figshare.33372258","doi":"https://doi.org/10.6084/m9.figshare.33372258","is_oa":true,"landing_page_url":"https://doi.org/10.6084/m9.figshare.33372258","pdf_url":null,"source":{"id":"https://openalex.org/S4377196282","display_name":"Figshare","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4210132348","host_organization_name":"Figshare (United Kingdom)","host_organization_lineage":["https://openalex.org/I4210132348"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"JournalArticle"},"sustainable_development_goals":[{"score":0.9763000011444092,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2537292256","https://openalex.org/W4410207394","https://openalex.org/W2781798643","https://openalex.org/W3214989551","https://openalex.org/W4416245782","https://openalex.org/W3095292730","https://openalex.org/W3028696784","https://openalex.org/W2587803379","https://openalex.org/W2528299152","https://openalex.org/W4224255951"],"abstract_inverted_index":{"Omalizumab,":[0],"a":[1,19,115,120,153,163],"humanized":[2],"anti-immunoglobulin":[3],"E":[4],"(IgE)":[5],"monoclonal":[6],"antibody":[7],"approved":[8],"for":[9,48],"chronic":[10,58],"spontaneous":[11],"urticaria":[12],"(CSU),":[13],"is":[14],"increasingly":[15],"used":[16],"off-label":[17],"across":[18],"range":[20],"of":[21,33,77],"dermatoses":[22],"linked":[23],"by":[24,114],"IgE-mediated":[25],"and":[26,45,52,70,81,101,119,176],"mast":[27],"cell\u2013driven":[28],"mechanisms,":[29,44],"exemplifying":[30],"the":[31,40,88,107,136,190],"concept":[32],"mechanism-based":[34],"drug":[35],"repositioning.":[36],"This":[37],"review":[38],"examines":[39],"molecular":[41],"pharmacology,":[42],"pleiotropic":[43],"clinical":[46],"evidence":[47],"omalizumab":[49,161],"in":[50,167],"established":[51],"emerging":[53],"dermatologic":[54],"indications,":[55],"including":[56],"CSU,":[57],"inducible":[59],"urticarias,":[60],"bullous":[61],"pemphigoid,":[62],"mastocytosis,":[63],"prurigo":[64],"nodularis,":[65],"hyper-IgE":[66],"syndrome,":[67],"eosinophilic":[68],"dermatoses,":[69],"other":[71],"refractory":[72],"conditions.":[73],"A":[74],"literature":[75],"search":[76],"PubMed,":[78],"Scopus,":[79],"Embase,":[80],"Google":[82],"Scholar":[83],"through":[84],"May":[85],"2026":[86],"informed":[87],"synthesis,":[89],"with":[90],"particular":[91],"emphasis":[92],"on":[93],"therapeutic":[94],"positioning":[95],"relative":[96],"to":[97,131],"newer":[98,172],"targeted":[99],"biologics":[100],"oral":[102,177],"agents.":[103],"Bullous":[104],"pemphigoid":[105],"represents":[106],"most":[108],"clinically":[109],"compelling":[110],"near-term":[111],"indication,":[112],"supported":[113],"coherent":[116],"autoreactive-IgE":[117],"rationale":[118],"candidate":[121],"predictive":[122],"biomarker":[123],"(anti-BP180":[124],"IgE);":[125],"biomarker-stratified":[126],"trials":[127,188],"are":[128],"now":[129],"essential":[130],"define":[132],"its":[133],"role":[134],"alongside":[135],"recently":[137],"FDA-approved":[138],"dupilumab.":[139],"Clinical":[140],"response":[141],"does":[142],"not":[143],"require":[144],"elevated":[145],"baseline":[146],"IgE,":[147],"arguing":[148],"against":[149],"serum":[150],"IgE":[151],"as":[152,162,171],"strict":[154],"selection":[155],"criterion.":[156],"Biosimilar":[157],"availability":[158],"may":[159],"reposition":[160],"cost-effective":[164],"option,":[165],"particularly":[166],"resource-limited":[168],"settings,":[169],"even":[170],"interleukin":[173],"IL-4/IL-13,":[174],"IL-31,":[175],"Bruton":[178],"tyrosine":[179],"kinase":[180],"(BTK)\u2013targeted":[181],"therapies":[182],"reshape":[183],"treatment":[184],"algorithms.":[185],"Biomarker-stratified":[186],"controlled":[187],"remain":[189],"principal":[191],"research":[192],"priority.":[193]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W7204605157","counts_by_year":[],"updated_date":"2026-10-28T10:33:24.094632","created_date":"2026-08-29T00:00:00"}
